Capital Flow Monitor · Sponsors · CIK 2069936
Caldera Therapeutics, Inc.
300 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 02139 · (781) 254-6624
Biotechnology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$37.5M
Sold
$37.5M
% sold
100.0%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-01-21 | D ·current | 506(b) | $37.5M | $37.5M | 100.0% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Praveen Tipirneni — Executive Officer / Director, Cambridge, MA
1 other raise
- Tasca Therapeutics Corp $48.1M of $70.2M · 68.5%
-
Michael Gladstone — Director, Cambridge, MA
1 other raise
- Atlas Venture Opportunity Fund Ill, L.P. $400.0M of $400.0M · 100.0%
-
Aaron Royston — Director, Cambridge, MA
1 other raise
- Arpeggio Biosciences, Inc. $20.0M of $35.3M · 56.7%
- Xiaodi Su — Director, Cambridge, MA
- Michelle Doig — Director, Cambridge, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.